Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Howell

Showing results (21-30 of 339) with videos related to

Pageof 34
Sort By:
Cancer Treatment Reviews|October 4, 2005
Clinical development of fulvestrant ("Faslodex")Anthony Howell, Paul Abram
Breast Cancer Research : BCR|January 9, 2009
Should lifestyle modifications be promoted to prevent breast cancer?Anthony Howell, Michelle Harvie
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Insights into the place of fulvestrant for the treatment of advanced endocrine responsive breast cancerAnthony Howell, Jonas Bergh
The Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Are aromatase inhibitors superior to antiestrogens?Anthony Howell, Aman Buzdar
The Journal of Steroid Biochemistry and Molecular Biology|June 7, 2005
Vascular effects of aromatase inhibitors: data from clinical trialsAnthony Howell, Jack Cuzick
Expert Review of Anticancer Therapy|July 13, 2002
Fulvestrant (Faslodex): current status in the therapy of breast cancerNigel Bundred, Anthony Howell
The Lancet. Oncology|March 10, 2012
Oestrogen and breast cancer: results from the WHI trialAnthony Howell, Jack Cuzick
The Proceedings of the Nutrition Society|March 15, 2012
Energy restriction and the prevention of breast cancerMichelle Harvie, Anthony Howell
Clinical Breast Cancer|July 7, 2011
Fulvestrant revisited: efficacy and safety of the 500-mg doseAnthony Howell, Francisco Sapunar
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 22, 2011
Hormone replacement therapy and breast cancerAnthony Howell, Gareth D Evans
Pageof 34

Showing results (21-30 of 339) with videos related to

Sort By:
Pageof 34
Cancer Treatment Reviews|October 4, 2005
Clinical development of fulvestrant ("Faslodex")Anthony Howell, Paul Abram
Breast Cancer Research : BCR|January 9, 2009
Should lifestyle modifications be promoted to prevent breast cancer?Anthony Howell, Michelle Harvie
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Insights into the place of fulvestrant for the treatment of advanced endocrine responsive breast cancerAnthony Howell, Jonas Bergh
The Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Are aromatase inhibitors superior to antiestrogens?Anthony Howell, Aman Buzdar
The Journal of Steroid Biochemistry and Molecular Biology|June 7, 2005
Vascular effects of aromatase inhibitors: data from clinical trialsAnthony Howell, Jack Cuzick
Expert Review of Anticancer Therapy|July 13, 2002
Fulvestrant (Faslodex): current status in the therapy of breast cancerNigel Bundred, Anthony Howell
The Lancet. Oncology|March 10, 2012
Oestrogen and breast cancer: results from the WHI trialAnthony Howell, Jack Cuzick
The Proceedings of the Nutrition Society|March 15, 2012
Energy restriction and the prevention of breast cancerMichelle Harvie, Anthony Howell
Clinical Breast Cancer|July 7, 2011
Fulvestrant revisited: efficacy and safety of the 500-mg doseAnthony Howell, Francisco Sapunar
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 22, 2011
Hormone replacement therapy and breast cancerAnthony Howell, Gareth D Evans
Pageof 34